Home › pSivida Corp. (PSDV) Upgraded to "Hold" at Zacks Investment Research
 

Keywords :   


pSivida Corp. (PSDV) Upgraded to "Hold" at Zacks Investment Research

2016-01-02 14:07:55| Biotech - Topix.net

According to Zacks, "pSivida Corp., a specialty pharmaceutical company, combines existing drugs with its sustained release delivery technologies to develop transformational products primarily in ophthalmology. pSivida's two proprietary technology systems are Durasert and Tethadur.

Tags: research hold investment corp

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11S
24.11
24.115
24.11SR
24.11 RC24.4.5
24.11115+128717dz
24.11lavaSUKALA 3
24.11508A
More »